NCT06007222View on ClinicalTrials.gov

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 6, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Aortic StenosisTAVI(Transcatheter Aortic Valve Implantation)AspirinDAPT(Dual Antiplatelet Therapy)SAPT(Single Antiplatelet Therapy)
Interventions
DRUG

Aspirin group

Aspirin 100mg will be started within 24 hours after randomization, and continued aspirin 100mg/day the end of the study period.

DRUG

Non-antithrombotic group

No antithrombotic agents will be administered after randomization until the end of the study period.

Trial Locations (1)

160-8582

RECRUITING

Keio University Hospital, Shinjuku

All Listed Sponsors
lead

OCEAN-SHD Study Group

OTHER